Detailed Category Analysis# Receptor Targets# Retatrutide : Triple agonist: GIP, GLP-1, and glucagon receptors simultaneously Tirzepatide : Dual agonist: GIP and GLP-1 receptors Advantage : Retatrutide Weight Loss Efficacy# Retatrutide : Up to 28.7% body weight reduction at 68 weeks (Phase 3 TRIUMPH-4)
It absorbs quickly, contains high leucine, and is easy to consume even when solid food is unappealing
Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats
What is the recommended dose of GLP-1 Medications
Over time, many patients choose to combine peptides with other treatments such as microneedling, skin treatments, or wellness therapies to support even better results
Premium Pharmaceutical Design